Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.
Choi J, Lee HJ, Yoon S, Ryu HM, Lee E, Jo Y, Seo S, Kim D, Lee CH, Kim W, Ha JY, Kim SY, Gong G, Jung KH, Park SR, Kim SW, Park KS, Lee DH.
Choi J, et al. Among authors: kim w, kim sw, kim d, kim sy.
Am J Cancer Res. 2020 Sep 1;10(9):2878-2894. eCollection 2020.
Am J Cancer Res. 2020.
PMID: 33042623
Free PMC article.